Virtu Financial’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-25,642
| Closed | -$475K | – | 2230 |
|
|
2023
Q3 | $475K | Buy |
+25,642
| New | +$290K | 0.05% | 367 |
|
|
2023
Q2 | – | Sell |
-17,609
| Closed | -$236K | – | 2294 |
|
|
2023
Q1 | $236K | Buy |
+17,609
| New | +$305K | 0.03% | 665 |
|
|
2022
Q4 | – | Sell |
-19,656
| Closed | -$274K | – | 2354 |
|
|
2022
Q3 | $274K | Buy |
+19,656
| New | +$317K | 0.03% | 699 |
|
|
2021
Q2 | – | Sell |
-11,921
| Closed | -$275K | – | 2231 |
|
|
2021
Q1 | $275K | Buy |
11,921
+2,010
| +20% | +$56K | 0.02% | 873 |
|
|
2020
Q4 | $245K | Buy |
+9,911
| New | +$328K | 0.03% | 751 |
|
|
2020
Q3 | – | Sell |
-25,025
| Closed | -$1.2M | – | 1656 |
|
|
2020
Q2 | $1.2M | Buy |
+25,025
| New | +$1.93M | 0.14% | 157 |
|
|
2019
Q4 | – | Sell |
-3,680
| Closed | -$244K | – | 1958 |
|
|
2019
Q3 | $244K | Buy |
+3,680
| New | +$247K | 0.02% | 863 |
|
|
2019
Q2 | – | Sell |
-3,209
| Closed | -$359K | – | 1972 |
|
|
2019
Q1 | $359K | Sell |
3,209
-2,133
| -40% | -$233K | 0.02% | 707 |
|
|
2018
Q4 | $538K | Buy |
+5,342
| New | +$554K | 0.03% | 458 |
|
|
2018
Q3 | – | Sell |
-2,651
| Closed | -$222K | – | 2357 |
|
|
2018
Q2 | $222K | Buy |
+2,651
| New | +$194K | 0.01% | 1424 |
|
|
2018
Q1 | – | Sell |
-4,003
| Closed | -$234K | – | 2780 |
|
|
2017
Q4 | $234K | Buy |
+4,003
| New | +$252K | 0.01% | 1507 |
|
|
2015
Q3 | – | Sell |
-1,457
| Closed | -$352K | – | 424 |
|
|
2015
Q2 | $352K | Buy |
+1,457
| New | +$388K | 0.03% | 242 |
|
Virtu Financial's ICPT Position: Q4 2023 in Review
Virtu Financial sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 25,642 shares — an estimated $475K sold.
Virtu Financial first reported a position in ICPT in Q2 2015 and held it in 12 quarters. The position peaked at $1.2M in Q2 2020. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- Virtu Financial reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Virtu Financial sold 25,642 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $475K.
- Virtu Financial first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2015 and held it in 12 quarters.
- Virtu Financial's Intercept Pharmaceuticals, Inc. position peaked at $1.2M in Q2 2020.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on Virtu Financial's 13F filing for Q4 2023, filed 26 Feb 2024.